Free Trial

Procter & Gamble (NYSE:PG) Shares Down 0.5% - Here's Why

Procter & Gamble logo with Consumer Staples background

Shares of The Procter & Gamble Company (NYSE:PG - Get Free Report) traded down 0.5% during mid-day trading on Monday . The company traded as low as $167.70 and last traded at $168.08. 1,553,678 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 6,642,572 shares. The stock had previously closed at $168.88.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Barclays lowered shares of Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 target price on the stock. in a report on Monday, September 30th. Deutsche Bank Aktiengesellschaft raised their price objective on Procter & Gamble from $171.00 to $176.00 and gave the stock a "buy" rating in a report on Wednesday, July 17th. Citigroup raised their target price on shares of Procter & Gamble from $177.00 to $190.00 and gave the stock a "buy" rating in a research report on Wednesday, July 10th. Wolfe Research raised shares of Procter & Gamble to a "strong-buy" rating in a research report on Friday, August 23rd. Finally, Piper Sandler started coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They issued a "neutral" rating and a $174.00 price target on the stock. Nine analysts have rated the stock with a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $175.89.

Get Our Latest Stock Report on Procter & Gamble

Procter & Gamble Stock Down 1.1 %

The company has a market cap of $394.31 billion, a price-to-earnings ratio of 27.34, a price-to-earnings-growth ratio of 3.73 and a beta of 0.41. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The stock has a 50-day simple moving average of $171.15 and a 200-day simple moving average of $166.55.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.37 by $0.03. The firm had revenue of $20.53 billion during the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. Procter & Gamble's revenue was down .1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.37 EPS. As a group, analysts predict that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were issued a $1.0065 dividend. The ex-dividend date was Friday, July 19th. This represents a $4.03 annualized dividend and a dividend yield of 2.41%. Procter & Gamble's dividend payout ratio (DPR) is 65.85%.

Insider Buying and Selling at Procter & Gamble

In related news, CFO Andre Schulten sold 13,041 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares in the company, valued at $6,325,360. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, CFO Andre Schulten sold 13,041 shares of the firm's stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the transaction, the chief financial officer now owns 37,208 shares of the company's stock, valued at approximately $6,325,360. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Balaji Purushothaman sold 8,842 shares of the business's stock in a transaction on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares in the company, valued at approximately $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 383,194 shares of company stock valued at $65,140,718. 0.17% of the stock is owned by insiders.

Hedge Funds Weigh In On Procter & Gamble

A number of large investors have recently made changes to their positions in the business. Itau Unibanco Holding S.A. bought a new stake in Procter & Gamble in the second quarter worth approximately $28,000. Fairway Wealth LLC acquired a new position in Procter & Gamble during the second quarter worth $29,000. Transcendent Capital Group LLC acquired a new stake in shares of Procter & Gamble in the fourth quarter worth about $31,000. Ruedi Wealth Management Inc. boosted its stake in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company's stock worth $32,000 after acquiring an additional 77 shares in the last quarter. Finally, POM Investment Strategies LLC bought a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $34,000. Institutional investors and hedge funds own 65.77% of the company's stock.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines